FDA Inspection 1167016 — Exogenesis Corporation
The FDA completed an inspection of Exogenesis Corporation on Apr 12, 2022 in Billerica, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Billerica, MA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3263 | 21 CFR 820.250(b) | Sampling plans |
| 541 | 21 CFR 820.70(c) | Environmental control Lack of or inadequate procedures |